Compass Financial Management LLC Purchases Shares of 3,098 Humana Inc. $HUM

Key Points

• Compass Financial Management acquired 3,098 Humana shares worth approximately $1.23 million in the second quarter. Institutional investors collectively own 92.38% of HUM.
• Several analysts recently upgraded Humana to “outperform,” although the broader analyst consensus remains “Hold”, with an average price target of $395.22.
• Humana exceeded quarterly expectations, reporting adjusted earnings of $7.61 per share and revenue of $40.89 billion, up 26.2% year over year.

Compass Financial Management LLC acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,098 shares of the insurance provider's stock, valued at approximately $1,229,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. Daiichi Life Insurance Co. Ltd. bought a new position in Humana in the 2nd quarter valued at about $980,000. Commerce Bank purchased a new stake in shares of Humana in the second quarter worth approximately $1,534,000. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Humana in the second quarter worth approximately $1,122,000. Evolve Private Wealth LLC bought a new position in shares of Humana in the second quarter valued at approximately $278,000. Finally, Westpac Banking Corp bought a new position in shares of Humana in the second quarter valued at approximately $230,000. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on HUM shares. Leerink Partners raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $513.00 price objective on the stock in a report on Thursday, July 30th. Wolfe Research upgraded Humana from a "peer perform" rating to an "outperform" rating in a research note on Thursday, July 30th. Guggenheim lifted their price objective on shares of Humana from $269.00 to $471.00 and gave the company a "buy" rating in a research note on Thursday, July 30th. Robert W. Baird set a $390.00 target price on Humana in a report on Thursday, July 30th. Finally, Evercore upgraded Humana from an "in-line" rating to an "outperform" rating and set a $480.00 price target on the stock in a research report on Wednesday, July 29th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $395.22.

Humana Trading Up 0.1%

Humana stock opened at $379.22 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The stock has a market cap of $45.54 billion, a P/E ratio of 35.88, a PEG ratio of 2.17 and a beta of 0.72. The firm's fifty day moving average price is $383.38 and its 200-day moving average price is $282.25.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter last year, the company earned $6.27 earnings per share. The firm's quarterly revenue was up 26.2% on a year-over-year basis. Equities research analysts forecast that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source